• Venture Debt
    • Ventures Portfolio
  • Equipment Leasing
    • Lease Financing
    • Capital Markets
    • Equipment Types
    • Services
    • Clients
  • Properties
  • Investors
    • Institutional Investors
    • Retail Investors
  • Resources
    • Insights
    • News
  • Company
    • Our Team
    • Careers
    • ATEL Foundation
    • Contact

True North Therapeutics

Life Sciences, Venture Debt

Focused on developing treatments for rare diseases mediated by the complement system. Acquired by Bioverativ in 2017.

Skills

Posted on

December 17, 2024

← Trilumina Twist Bioscience →

ATEL Capital Group
505 Montgomery St., 7th Floor
San Francisco, CA 94111

info@atel.com
(415) 989-8800

Venture Debt

Ventures Portfolio

Leasing

Lease Financing

Capital Markets

Equipment Types

Equipment Services

Clients

Properties

Investors

Institutional Investors

Retail Investors

Resources

Insights

News

Company

Our Team

Careers

Contact

© ATEL Capital Group 2025

Privacy Policy